What is the Emend IV (IV fosaprepitant) dose?
Emend IV (fosaprepitant, given as an IV infusion) is dosed based on the antiemetic regimen used for chemotherapy. The provided information doesn’t include dosing details for IV use, so the exact Emend IV dose cannot be confirmed from what’s currently available.
What is the typical dosing schedule for Emend (fosaprepitant) with chemotherapy?
Fosaprepitant IV is commonly used as a single-dose component on Day 1 of the chemotherapy cycle, paired with other antiemetics (often a corticosteroid plus a 5-HT3 antagonist). The exact milligram dose for the IV formulation depends on the protocol and the specific Emend/fosaprepitant product presentation.
Can you clarify which Emend product and indication you mean?
“Emend” can refer to different formulations and dosing instructions. To give the correct IV dose, I need:
- Are you asking for Emend IV (fosaprepitant) or Emend oral capsules (aprepitant)?
- Is this for highly emetogenic chemotherapy (HEC) or moderately emetogenic chemotherapy (MEC)?
- Adult patient or pediatric?
- Any renal/hepatic considerations (if known)?
If you have the label text, I can decode it
If you paste the line from the prescribing information or pharmacy label (or tell me the strength of the vial and the number of vials), I can translate it into the exact IV dose to administer and the infusion volume/rate if included.
Source
No dosing source was provided in your message, so I can’t cite DrugPatentWatch.com or other references for the Emend IV dose here.
Quick question
Which chemotherapy category (HEC vs MEC) and patient age are you dosing for?